Characterization of long-term responders to first treatment course of rituximab (RTX) - Results from the CERERRA collaboration.

Elisabeth Lie; Katerina Chatzidionysiou; Evgeny L. Nasonov; Galina Lukina; Karel Pavelka; Dan C. Nordström; Matija Tomsic; Cem Gabay; Ioan Ancuta; Piet L.C. van Riel; Juan J. Gomez-Reino; João E. Fonseca; Merete Lund Hetland; Ulrik Tarp; Tore K. Kvien; Ronald F. van Vollenhoven

Characterization of long-term responders to first treatment course of rituximab (RTX) - Results from the CERERRA collaboration.

Elisabeth Lie, Katerina Chatzidionysiou, Evgeny L. Nasonov, Galina Lukina, Karel Pavelka, Dan C. Nordström, Matija Tomsic, Cem Gabay, Ioan Ancuta, Piet L.C. van Riel, Juan J. Gomez-Reino, João E. Fonseca, Merete Lund Hetland, Ulrik Tarp, Tore K. Kvien, Ronald F. van Vollenhoven

Department of Clinical Medicine

89 Citations (Scopus)

Original language	English
Journal	Arthritis & Rheumatism
Volume	63
Issue number	10 (Suppl.)
Pages (from-to)	S877
Number of pages	1
ISSN	0004-3591
Publication status	Published - 2011

Cite this

Lie, E., Chatzidionysiou, K., Nasonov, E. L., Lukina, G., Pavelka, K., Nordström, D. C., Tomsic, M., Gabay, C., Ancuta, I., van Riel, P. L. C., Gomez-Reino, J. J., Fonseca, J. E., Hetland, M. L., Tarp, U., Kvien, T. K., & van Vollenhoven, R. F. (2011). Characterization of long-term responders to first treatment course of rituximab (RTX) - Results from the CERERRA collaboration. Arthritis & Rheumatism, 63(10 (Suppl.)), S877.

Characterization of long-term responders to first treatment course of rituximab (RTX) - Results from the CERERRA collaboration. / Lie, Elisabeth; Chatzidionysiou, Katerina; Nasonov, Evgeny L. et al.

In: Arthritis & Rheumatism, Vol. 63, No. 10 (Suppl.), 2011, p. S877.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Lie, E, Chatzidionysiou, K, Nasonov, EL, Lukina, G, Pavelka, K, Nordström, DC, Tomsic, M, Gabay, C, Ancuta, I, van Riel, PLC, Gomez-Reino, JJ, Fonseca, JE, Hetland, ML, Tarp, U, Kvien, TK & van Vollenhoven, RF 2011, 'Characterization of long-term responders to first treatment course of rituximab (RTX) - Results from the CERERRA collaboration.', Arthritis & Rheumatism, vol. 63, no. 10 (Suppl.), pp. S877.

@article{e06f14a78f314336974e6bc9b0954953,

title = "Characterization of long-term responders to first treatment course of rituximab (RTX) - Results from the CERERRA collaboration.",

author = "Elisabeth Lie and Katerina Chatzidionysiou and Nasonov, {Evgeny L.} and Galina Lukina and Karel Pavelka and Nordstr{\"o}m, {Dan C.} and Matija Tomsic and Cem Gabay and Ioan Ancuta and {van Riel}, {Piet L.C.} and Gomez-Reino, {Juan J.} and Fonseca, {Jo{\~a}o E.} and Hetland, {Merete Lund} and Ulrik Tarp and Kvien, {Tore K.} and {van Vollenhoven}, {Ronald F.}",

year = "2011",

language = "English",

volume = "63",

pages = "S877",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "10 (Suppl.)",

}

TY - ABST

T1 - Characterization of long-term responders to first treatment course of rituximab (RTX) - Results from the CERERRA collaboration.

AU - Lie, Elisabeth

AU - Chatzidionysiou, Katerina

AU - Nasonov, Evgeny L.

AU - Lukina, Galina

AU - Pavelka, Karel

AU - Nordström, Dan C.

AU - Tomsic, Matija

AU - Gabay, Cem

AU - Ancuta, Ioan

AU - van Riel, Piet L.C.

AU - Gomez-Reino, Juan J.

AU - Fonseca, João E.

AU - Hetland, Merete Lund

AU - Tarp, Ulrik

AU - Kvien, Tore K.

AU - van Vollenhoven, Ronald F.

PY - 2011

Y1 - 2011

M3 - Conference abstract in journal

SN - 2326-5205

VL - 63

SP - S877

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 10 (Suppl.)

ER -